First Trust NYSE Arca Biotechnology Index Fund

Frequently Asked Questions About FBT

What does FBT invest in?

The First Trust NYSE Arca Biotechnology Index Fund (FBT) is an exchange-traded fund (ETF) designed with a clear purpose: to accurately reflect the price movements and income generated by the NYSE Arca Biotechnology Index. Its core objective is to closely match the performance of this benchmark index, before accounting for the fund's operational fees and expenses.

What is the expense ratio of FBT?

First Trust NYSE Arca Biotechnology Index Fund (FBT) charges an expense ratio of 0.55%. This is the annual fee deducted from fund assets to cover management and operations.

How big is FBT?

First Trust NYSE Arca Biotechnology Index Fund (FBT) manages $2.82B in total assets. AUM determines bid-ask liquidity and the fund's vulnerability to closure — funds below ~$50M are at higher risk of liquidation.

Is FBT actively managed or an index fund?

FBT's management style is described in the fund's prospectus. See the description on the Summary tab for the published strategy.

When was FBT launched?

First Trust NYSE Arca Biotechnology Index Fund (FBT) launched in June 2006 and is managed by First Trust.

How has FBT performed?

FBT's total return — price change plus reinvested distributions — is charted at the top of this page. Switch the price chart to Total Return and pick a 1-year, 3-year, 5-year, or 10-year window to read the compound annual growth rate (CAGR) over each horizon.